GFACX
Price
$73.04
Change
+$0.40 (+0.55%)
Updated
Sep 11 closing price
Net Assets
353.07B
MDFGX
Price
$31.66
Change
+$0.39 (+1.25%)
Updated
Sep 11 closing price
Net Assets
3.78B
Interact to see
Advertisement

GFACX vs MDFGX

GFACX vs MDFGX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. MDFGX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and MDFGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 353B vs. MDFGX (3.78B). GFACX (0.00) and MDFGX (0.00) have matching dividends . GFACX was incepted earlier than MDFGX: GFACX (26 years) vs MDFGX (29 years). GFACX (1.35) is less costly to investors than MDFGX (0.97). MDFGX is a more actively managed with annual turnover of: 99.00 vs. GFACX (32.00). GFACX has a lower initial minimum investment than MDFGX: GFACX (250) vs MDFGX (1000). GFACX annual gain was more profitable for investors over the last year : -2.39 vs. MDFGX (-17.53). GFACX return over 5 years is better than : 3.85 vs. MDFGX (-21.56).
GFACXMDFGXGFACX / MDFGX
Total Expense Ratio1.350.92147%
Annual Report Gross Expense Ratio1.350.97139%
Fund Existence26 years29 years-
Gain YTD8.529-8.997-95%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets353B3.78B9,341%
Annual Yield % from dividends0.000.00-
Returns for 1 year-2.39-17.5314%
Returns for 3 years34.467.18480%
Returns for 5 years3.85-21.56-18%
Returns for 10 years82.3337.89217%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DXR11.400.35
+3.17%
Daxor Corp
WSE12.020.09
+0.75%
Wise Group Plc
GPACU10.16N/A
N/A
General Purpose Acquisition Corp
CC15.03-0.04
-0.27%
Chemours Company (The)
KYTX7.26-0.09
-1.22%
Kyverna Therapeutics